On the other hand, Liraglutide, which requires daily injections, may be more suited to patients who need more immediate effects due to its shorter half-life but are comfortable with daily injections
If youve looked into GLP-1 therapy for weight loss, youve almost certainly run into both semaglutide and tirzepatide
Great customer service, helped me whenever I reached out
What they're saying: According to the lawsuit, one of the plaintiffs switched from Zepbound to Wegovy in August after exhausting all appeals to Caremark, then "experienced a number of side effects, including the return of his Gastroesophageal Reflux Disease, stomach pain, hunger, and, most notably, weight gain." "Because of their different methods of action, different clinical outcomes, and different side effects for individual patients, Zepbound and Wegovy are not clinically interchangeable," the lawsuit states